(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-25 View latest technical analysis
10 day averaged volume of Ligand Pharmaceuticals is 98640
Date | Daily Closing Price | Open | High | Low | Volume |
25 Tue Feb 2025 | 118.70 | 117.07 | 119.59 | 114.77 | 1.039 times |
24 Mon Feb 2025 | 117.07 | 120.81 | 120.92 | 116.99 | 0.965 times |
21 Fri Feb 2025 | 120.67 | 123.02 | 123.02 | 119.02 | 1.386 times |
20 Thu Feb 2025 | 122.01 | 122.13 | 122.91 | 119.54 | 1.5 times |
19 Wed Feb 2025 | 122.00 | 118.86 | 122.62 | 118.23 | 1.08 times |
18 Tue Feb 2025 | 119.99 | 120.25 | 121.65 | 117.63 | 1.245 times |
14 Fri Feb 2025 | 120.00 | 114.03 | 121.26 | 113.58 | 1.205 times |
13 Thu Feb 2025 | 113.93 | 111.76 | 115.99 | 111.52 | 0.686 times |
12 Wed Feb 2025 | 111.39 | 110.81 | 112.66 | 110.42 | 0.79 times |
11 Tue Feb 2025 | 112.77 | 114.75 | 114.75 | 111.19 | 0.604 times |
My analysis of stock is bullish for shortterm, and stock might move up till 120.2 or till 123.7. Use a stoploss of 117.36 and if this stock hits its stoploss, then it can fall down till 114.48
Share price targets for Ligand Pharmaceuticals (LGND)
Target Type | Value |
Downside Target | 97.78 |
Downside Target | 102.79 |
Downside Target | 105.00 |
Downside Target | 110.42 |
Downside Target | 113.27 |
Upside Target | 121.26 |
Upside Target | 122.34 |
Upside Target | 123.02 |
Upside Target | 125.50 |
Upside Target | 129.90 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
Target Type | Value |
Downside Intraday Target | 115.34 |
Downside Intraday Target | 111.98 |
Upside Intraday Target | 121.49 |
Upside Intraday Target | 124.28 |
Downside Intraday Target | 118.13 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Tue Feb 2025 | 118.70 | 120.81 | 120.92 | 114.77 | 0.385 times |
21 Fri Feb 2025 | 120.67 | 120.25 | 123.02 | 117.63 | 1.363 times |
14 Fri Feb 2025 | 120.00 | 115.12 | 121.26 | 110.42 | 1.236 times |
07 Fri Feb 2025 | 115.19 | 113.76 | 119.26 | 113.27 | 0.846 times |
31 Fri Jan 2025 | 116.55 | 114.75 | 122.34 | 114.75 | 0.96 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Tue Feb 2025 | 118.70 | 113.76 | 123.02 | 110.42 | 0.724 times |
31 Fri Jan 2025 | 116.55 | 108.12 | 122.34 | 102.79 | 0.841 times |
31 Tue Dec 2024 | 107.15 | 124.78 | 125.50 | 105.00 | 0.789 times |
26 Tue Nov 2024 | 124.33 | 107.05 | 129.90 | 107.05 | 1.406 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Ligand Pharmaceuticals in short term and the buy signal is strong.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 118.72 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Ligand Pharmaceuticals in short term and the buy signal is strong.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 118.72 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.